{
    "Variants Include": [
        {
            "Gene": "R-synuclein (RS)",
            "variants": [
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "K",
                        "position": "46"
                    },
                    "Description in input context": "E46K"
                },
                {
                    "HGVS": "N.D.",
                    "cDNA Change": {
                        "transcript": "N.D.",
                        "ref": "N.D.",
                        "alt": "N.D.",
                        "position": "N.D."
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "53"
                    },
                    "Description in input context": "A53T"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson's disease (PD)",
        "MONDO": "MONDO:0005200"
    },
    "Experiment Method": [
        {
            "Assay Method": "Protein Expression and Purification",
            "Material used": {
                "Material Source": "Recombinant plasmids",
                "Material Name": "Human wild - type RS, A30P RS, E46K RS, A53T RS",
                "Description": "Human wild - type RS with 15N and 2H isotopic enrichment was expressed and purified by anion - exchange chromatography. A30P, E46K, and A53T RS were expressed from recombinant plasmids produced by mutagenesis of the wild - type sequence using Quikchange mutagenesis reagents and standard PCR techniques."
            },
            "Readout type": "N.D.",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "N.D."
            }
        },
        {
            "Assay Method": "Preparation of Lipid Vesicles",
            "Material used": {
                "Material Source": "Purchased lyophilized mixture",
                "Material Name": "5:3:2 DOPE/DOPS/DOPC",
                "Description": "Phospholipids were purchased as a lyophilized mixture (5:3:2 DOPE/DOPS/DOPC) from Avanti Polar Lipids and used without further purification. A 15% (w/v) stock solution of small unilamellar vesicles (SUVs) was prepared. Large unilamellar vesicles (LUVs) were prepared by multiple cycles of extrusion using the Avanti Polar Lipids mini - extruder through membranes with a 100 nm pore size."
            },
            "Readout type": "N.D.",
            "Readout description": [
                {
                    "Variant": "N.D.",
                    "Conclusion": "N.D.",
                    "Molecular Effect": "N.D.",
                    "Result Description": "N.D."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "N.D."
            }
        },
        {
            "Assay Method": "NMR Spectroscopy",
            "Material used": {
                "Material Source": "Lyophilized protein",
                "Material Name": "WT, A30P, E46K, A53T RS",
                "Description": "Samples were prepared from lyophilized protein dissolved in 20 mM Na2HPO4 (pH 6.0), a 94% H2O/6% D2O mixture, and 0.02% NaN3."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "A30P",
                    "Conclusion": "A30P has lower lipid affinity in most N - terminal residues, altered binding mode ratio (SL1/SL2 increased), slower lipid association rate",
                    "Molecular Effect": "Altered lipid - binding kinetics and mode distribution",
                    "Result Description": "The lipid binding affinity of the first 10 N - terminal residues of A30P RS approaches that of the wild - type protein. Residues 11 - 23 have increasing resonance intensity. From residue 25, ∼25% of A30P RS residues 25 - 100 are in a lipid - bound state. The overall bound population of A30P RS is 54% bound. The ratio of SL1 to SL2 binding modes is greatly increased. The association rate for region V26 - T33 is decreased."
                },
                {
                    "Variant": "E46K",
                    "Conclusion": "E46K has higher overall lipid partitioning, increased SL1 population, slower lipid dissociation rate",
                    "Molecular Effect": "Increased lipid - binding affinity and altered dissociation kinetics",
                    "Result Description": "E46K RS variant displays an overall higher level of lipid partitioning of SL1, SL2, and all intermediate modes. The mutation raises the net charge, favoring interactions with SUVs. The increased affinity increases the population of SL1 by ∼25%. The dissociation rate is slowed by a factor of >2."
                },
                {
                    "Variant": "A53T",
                    "Conclusion": "A53T has a subtle effect on lipid binding, modest elevation of SL1 binding mode, similar overall binding affinity to wild - type",
                    "Molecular Effect": "Subtle alteration in lipid - binding mode distribution",
                    "Result Description": "The attenuation profile of A53T is only slightly offset from the WT curve. There is a modest elevation of the SL1 binding mode, and the overall binding affinity appears similar to that of the wild - type. It also exhibits an increase in the ratio of SL1 - to SL2 - bound populations."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "N.D.",
                "Description": "N.D."
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "N.D.",
                "Description": "N.D."
            },
            "Basic negative control": {
                "Basic negative control": "N.D.",
                "Description": "N.D."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}